Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies.
A conceptual shift from conventional MDR models toward systemic adaptive resistance is proposed, and classical drug resistance, including drug uptake/efflux, compensatory pathway activation, and apoptosis evasion is reviewed.